Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma

NCT05293158 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT05293158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05293158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma
Lead sponsor
Medical University of Graz
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2024
Completion date
June 30, 2026
Enrollment
5 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hbv, hepatocellular carcinoma